Front Cover, Volume 40, Issue 9
Natàlia Padilla
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorAlejandro Moles-Fernández
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorCasandra Riera
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorGemma Montalban
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorSelen Özkan
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorLars Ootes
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorSandra Bonache
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorOrland Díez
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Area of Clinical and Molecular Genetics, University Hospital of Vall d’Hebron, Barcelona, Spain
Search for more papers by this authorCorresponding Author
Sara Gutiérrez-Enríquez
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]
Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]
Search for more papers by this authorCorresponding Author
Xavier de la Cruz
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]
Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]
Search for more papers by this authorNatàlia Padilla
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorAlejandro Moles-Fernández
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorCasandra Riera
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorGemma Montalban
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorSelen Özkan
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorLars Ootes
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Search for more papers by this authorSandra Bonache
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for more papers by this authorOrland Díez
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Area of Clinical and Molecular Genetics, University Hospital of Vall d’Hebron, Barcelona, Spain
Search for more papers by this authorCorresponding Author
Sara Gutiérrez-Enríquez
Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]
Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]
Search for more papers by this authorCorresponding Author
Xavier de la Cruz
Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]
Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]
Search for more papers by this authorCarli, Giorgio, Ferrero, Brusco, and Tartaglia have contributed equally to this work.
Graphical Abstract
Outside Front Cover: The cover image is based on the Special Article BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge by Natàlia Padilla et al., https://doi.org/10.1002/humu.23802.
Cover design: Selen Özkan and Xavier de la Cruz.